Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Apollo Endosurgery (APEN) stocks in Canada

Learn how to easily invest in Apollo Endosurgery stocks.

Apollo Endosurgery is a medical devices business based in the US. Apollo Endosurgery stocks (APEN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $7.9 – a decrease of 9.73% over the previous week. Apollo Endosurgery employs 158 staff and has a trailing 12-month revenue of around $59.7 million.

How to buy shares in Apollo Endosurgery

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – APEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Apollo Endosurgery stock price (NASDAQ:APEN)

Use our graph to track the performance of APEN stocks over time.

Apollo Endosurgery shares at a glance

Information last updated 2022-01-25.
Latest market close$5.01
52-week range$4.11 - $10.39
50-day moving average $8.00
200-day moving average $8.06
Wall St. target price$12.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.66

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Apollo Endosurgery stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Apollo Endosurgery price performance over time

Historical closes compared with the close of $5.01 from 2022-01-27

1 week (2022-01-19) -13.77%
1 month (2021-12-24) N/A
3 months (2021-10-24) N/A
6 months (2021-07-28) -36.34%
1 year (2021-01-28) 14.91%
2 years (2020-01-28) 64.26%
3 years (2019-01-28) 38.78%
5 years (2017-01-27) 13.06

Apollo Endosurgery financials

Revenue TTM $59.7 million
Gross profit TTM $22.2 million
Return on assets TTM -13.79%
Return on equity TTM -344.38%
Profit margin -29.8%
Book value $0.10
Market capitalisation $218 million

TTM: trailing 12 months

Apollo Endosurgery share dividends

We're not expecting Apollo Endosurgery to pay a dividend over the next 12 months.

Have Apollo Endosurgery's shares ever split?

Apollo Endosurgery's shares were split on a 10:55 basis on 29 December 2016. So if you had owned 55 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Apollo Endosurgery shares – just the quantity. However, indirectly, the new 450% higher share price could have impacted the market appetite for Apollo Endosurgery shares which in turn could have impacted Apollo Endosurgery's share price.

Apollo Endosurgery share price volatility

Over the last 12 months, Apollo Endosurgery's shares have ranged in value from as little as $4.11 up to $10.39. A popular way to gauge a stock's volatility is its "beta".

APEN.US volatility(beta: 2.2)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Endosurgery's is 2.2022. This would suggest that Apollo Endosurgery's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Apollo Endosurgery overview

Apollo Endosurgery, Inc. , a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site